市販の痛み止めの世界市場

市販の痛み止めの世界市場は2030年までに309億米ドルに達する見込み

2024年に263億米ドルと推定される市販の痛み止めの世界市場は、2024～2030年の分析期間においてCAGR 2.7%で成長し、2030年には309億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである非ステロイド性抗炎症薬は、CAGR 2.1%を記録し、分析期間終了時には121億米ドルに達すると予想されます。局所麻酔薬セグメントの成長率は、分析期間中CAGR 2.7%と推定されます。

米国市場は72億米ドルと推定、中国はCAGR 5.0％で成長予測

米国の市販の痛み止め市場は、2024年に72億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに59億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.0%と予測されています。欧州では、ドイツがCAGR 1.5%で成長すると予測されています。

世界の市販の痛み止め市場- 主要動向と促進要因まとめ

なぜ市販の痛み止めが世界の数百万人の治療の第一選択なのか？

市販の痛み止めは、頭痛、筋肉痛、腰痛、生理痛、関節炎、軽いケガなど、一般的な症状を簡単に入手でき、即効性があるため、現代のヘルスケアに欠かせない役割を果たしています。これらの薬は、主にアセトアミノフェン（パラセタモール）、イブプロフェン、ナプロキセン、アスピリンなどであり、正式な診察を受ける前に最初に介入されることが多いです。処方箋なしで広く入手可能であり、治療範囲が広く、（適切に使用された場合の）安全性が高いことから、世界中で消費者のセルフケアの要となっています。

慢性疼痛疾患の有病率の上昇、座りがちなライフスタイル、高齢化により、OTC鎮痛薬への需要が高まっています。健康リテラシーの向上、デジタルヘルスプラットフォームや薬剤師によるセルフメディケーションの普及により、消費者は軽度から中等度の疼痛を独自に管理できるようになりました。さらに、不必要なオピオイドの使用を制限しようとする公衆衛生の取り組みにより、OTC鎮痛剤は重度でない痛みに対してより安全な代替薬として位置づけられています。OTC鎮痛剤は低コストで、ブランド認知度が高く、作用発現が速いため、地域や人口構成を問わず、日常的な健康習慣に組み込まれています。

製剤革新と併用療法は、OTC鎮痛薬の有用性をどのように拡大しているか？

OTC鎮痛薬市場における製品革新は、送達メカニズムの強化、多症候性製剤、消費者の利便性に焦点を当てています。液状ゲル、発泡性錠剤、ソフトチュー、経皮パッチ、局所用ゲルなどが、吸収率の向上や特定の疼痛タイプに対応するために開発されています。アセトアミノフェンにカフェイン、イブプロフェンに制酸剤を配合した二成分製剤は、頭痛、片頭痛、胃腸の不快感に対する機能を拡大しています。さらに、より少ない服用量で長時間緩和をもたらす12時間錠や徐放錠も登場しています。

ウコン、アルニカ、メントール、カンナビジオール（CBD）などを配合した天然素材やハーブのOTC鎮痛剤は、代替治療や補助治療を求める消費者の間で人気を集めています。小児用および高齢者用の製剤は現在、低用量、小児用包装、香味マスキングを特徴とし、服薬アドヒアランスと安全性を向上させています。QRコードから投与量計算や安全警告にリンクするなどのデジタル統合も、ユーザー教育を強化しています。こうした開発は、進化する消費者の期待に応えるだけでなく、競合情勢が激化する中で製品の差別化を推進するものでもあります。

OTC鎮痛剤市場の成長を促進する人口動態と小売エコシステムは？

OTC鎮痛剤の幅広い有用性はほぼすべての年齢層に及んでいるが、特定の層が独自の需要動向を牽引しています。女性は月経痛、片頭痛、筋骨格系の痛みにOTC鎮痛剤をよく使う。高齢者は、変形性関節症、関節痛、慢性炎症性疾患のためにこれらの医薬品を利用しているが、用量の調節と消化器系の安全性には懸念が残る。若年層、特にフィットネスや活動的なライフスタイルを送る人々は、スポーツによる怪我や回復のために即効性のある鎮痛剤を使用しています。

小売薬局、スーパーマーケット、eコマース・プラットフォームが流通の中心となっています。特にオンライン・チャネルは、定期購入モデル、一括割引、健康とウェルネスのバンドルによって急成長しています。アジア、ラテンアメリカ、アフリカの新興市場では、公衆衛生教育キャンペーン、小売インフラの拡大、中間所得層の所得増加により、導入が進んでいます。北米と欧州は技術革新と法規制遵守の面で引き続きリードしており、アジア太平洋は販売数量とブランド普及の面で最も急成長している地域です。

OTC鎮痛薬市場の長期的成長と競合市場競争の原動力は？

OTC鎮痛薬市場の成長の原動力は、慢性疼痛の蔓延、セルフケアの動向、ヘルスケアコスト抑制戦略です。ヘルスケアシステムが世界的に予防医療とクリニカル・パスウェイの混雑緩和を優先する中、OTC医薬品は緊急時以外の疼痛管理に低リスクで費用対効果の高いソリューションを提供しています。薬剤師による処方や指導によるOTC薬の使用に対する規制当局のサポートが強化され、利用しやすさと責任ある使用が拡大しています。

市場リーダーは、ブランドエクイティ、有効成分の最適化、ポートフォリオの多様化のための戦略的買収に投資しています。遠隔医療プラットフォーム、モバイルヘルスアプリ、ウェアラブルとの連携により、疼痛モニタリングやOTC製品推奨のための新たなチャネルが開かれつつあります。パッケージの持続可能性、クリーンラベル成分の配合、ソーシャルメディア・マーケティング・キャンペーンは、環境意識が高く、デジタルに積極的な消費者の共感を呼んでいます。疼痛緩和はセルフメディケーションの中でも使用頻度の高いユースケースであり続けるため、OTC市場は今後も弾力性があり、イノベーション主導型の消費者志向のヘルスケア分野であり続けると思われます。

セグメント

薬剤クラス（非ステロイド性抗炎症薬、局所麻酔薬、アセトアミノフェン、サリチル酸塩、その他の薬剤クラス）、投与経路（経口、局所、その他の投与経路）、剤形（錠剤／カプセル、液体、クリーム、ゲル、その他の剤形）、流通チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例（全42件）

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Bayer AG
• Boehringer Ingelheim GmbH
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc
• Haleon plc
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Lupin Limited
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Over-the-Counter Pain Medication Market to Reach US$30.9 Billion by 2030

The global market for Over-the-Counter Pain Medication estimated at US$26.3 Billion in the year 2024, is expected to reach US$30.9 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Non-steroidal Anti-inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$12.1 Billion by the end of the analysis period. Growth in the Local Anesthetics segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.2 Billion While China is Forecast to Grow at 5.0% CAGR

The Over-the-Counter Pain Medication market in the U.S. is estimated at US$7.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Over-the-Counter Pain Medication Market - Key Trends & Drivers Summarized

Why Are Over-the-Counter Pain Medications the First Line of Treatment for Millions Worldwide?

Over-the-counter (OTC) pain medications play an indispensable role in modern healthcare by providing easily accessible, fast-acting relief for common conditions such as headaches, muscle pain, backaches, menstrual cramps, arthritis, and minor injuries. These medications-chiefly acetaminophen (paracetamol), ibuprofen, naproxen, and aspirin-are often the first point of intervention before formal medical consultation. Their widespread availability without a prescription, broad therapeutic range, and strong safety profile (when used appropriately) have made them a cornerstone of consumer self-care worldwide.

The rising prevalence of chronic pain conditions, sedentary lifestyles, and aging populations has reinforced demand for OTC analgesics. Increasing health literacy, along with digital health platforms and pharmacist-guided self-medication, has empowered consumers to manage mild-to-moderate pain independently. Moreover, public health efforts to limit unnecessary opioid use have positioned OTC pain relievers as a safer alternative for non-severe pain. Their low cost, brand familiarity, and rapid onset of action have ensured that these drugs remain embedded in daily health routines across geographies and demographics.

How Are Formulation Innovations and Combination Therapies Expanding the Utility of OTC Analgesics?

Product innovation in the OTC pain relief market is focusing on enhanced delivery mechanisms, multi-symptom formulations, and consumer convenience. Liquid gels, effervescent tablets, soft chews, transdermal patches, and topical gels are being developed to improve absorption rates and target specific pain types. Dual-ingredient products combining acetaminophen with caffeine or ibuprofen with antacids are expanding functionality for headaches, migraines, and gastrointestinal comfort. Additionally, 12-hour or extended-release tablets are being introduced to provide prolonged relief with fewer doses.

Natural and herbal OTC pain relievers-incorporating turmeric, arnica, menthol, or cannabidiol (CBD)-are gaining popularity among consumers seeking alternative or adjunctive treatments. Pediatric and geriatric formulations now feature lower dosages, child-proof packaging, and flavor masking to improve adherence and safety. Digital integration, such as QR codes linking to dosage calculators and safety warnings, is also enhancing user education. These developments are not only meeting evolving consumer expectations but also driving product differentiation in an increasingly competitive landscape.

Which Demographics and Retail Ecosystems Are Propelling Growth in the OTC Pain Relief Market?

The broad utility of OTC analgesics spans virtually all age groups, but specific demographics are driving unique demand trends. Women frequently use OTC pain relievers for menstrual cramps, migraines, and musculoskeletal pain. Older adults rely on these medications for osteoarthritis, joint pain, and chronic inflammatory conditions, although dosage adjustment and GI safety remain concerns. Younger consumers, particularly those engaged in fitness and active lifestyles, use fast-acting pain relievers for sports injuries and recovery routines.

Retail pharmacies, supermarkets, and e-commerce platforms dominate distribution. Online channels, in particular, are growing rapidly due to subscription models, bulk discounts, and health-and-wellness bundles. Emerging markets in Asia, Latin America, and Africa are experiencing increased adoption through public health education campaigns, expanded retail infrastructure, and growing middle-class income. North America and Europe continue to lead in innovation and regulatory compliance, while Asia-Pacific represents the fastest-growing region in terms of unit volumes and brand proliferation.

What Is Driving Long-Term Growth and Competitive Innovation in the OTC Pain Medication Market?

The growth in the OTC pain medication market is driven by chronic pain prevalence, self-care trends, and healthcare cost containment strategies. As healthcare systems globally prioritize preventive care and decongestion of clinical pathways, OTC medications offer a low-risk, cost-effective solution for non-emergency pain management. Increased regulatory support for pharmacist-prescribed or guided OTC use is expanding accessibility and responsible usage.

Market leaders are investing in brand equity, active ingredient optimization, and strategic acquisitions to diversify their portfolios. Collaborations with telehealth platforms, mobile health apps, and wearables are opening new channels for pain monitoring and OTC product recommendation. Sustainability in packaging, inclusion of clean-label ingredients, and social media marketing campaigns are further resonating with eco-conscious and digitally engaged consumers. As pain relief continues to be a high-frequency use case in self-medication, the OTC market is set to remain a resilient, innovation-driven, and consumer-aligned healthcare segment.

SCOPE OF STUDY:

The report analyzes the Over-the-Counter Pain Medication market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates, Other Drug Classes); Administration Route (Oral, Topical, Other Administration Routes); Dosage Form (Tablets / Capsules, Liquids, Creams, Gels, Other Dosage Forms); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Bayer AG
• Boehringer Ingelheim GmbH
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline plc
• Haleon plc
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Lupin Limited
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Over-the-Counter Pain Medication - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Consumer Preference for Self-Care and Immediate Relief Propels Demand for OTC Pain Medications
  • Expansion of E-Pharmacy Platforms Strengthens Direct Access to Non-Prescription Analgesics
  • Increased Incidence of Musculoskeletal and Lifestyle-Induced Pain Drives Repeat Use of OTC Options
  • Availability of Combination Formulations With Multi-Symptom Relief Throws the Spotlight on Product Innovation
  • Regulatory Reclassification of Former Prescription Medications Spurs Market Expansion in OTC Channels
  • Emphasis on Label Transparency and Ingredient Clarity Enhances Consumer Confidence
  • Growing Aging Population and Arthritis Cases Propel Demand for Long-Term Pain Management Solutions
  • Launch of Extended-Release and Fast-Acting Pain Relievers Improves Patient Compliance
  • Widening Use of Topical and Patch-Based OTC Analgesics Expands Non-Oral Product Categories
  • Emergence of Pediatric and Teen-Specific Pain Relief Products Expands Demographic Reach
  • Rising Demand for Natural and Herbal OTC Alternatives Supports Clean Pain Management Trends
  • Increased Regulatory Monitoring on Opioid Use Reinforces Shift Toward Safer OTC Pain Relievers
  • Integration of QR Codes and Mobile Apps for Dosing Guidance Supports Responsible Self-Medication
  • Collaborations Between OTC Brands and Fitness Retailers Drive Cross-Selling Opportunities
  • Availability of Pain-Specific Supplements Enhances Competition for Traditional OTC Analgesics
  • Awareness Campaigns on Pain Type Differentiation Improve Targeted Product Positioning
  • Innovation in Dual-Action Pain Relief With Anti-Inflammatory and Muscle Relaxants Propels Market Differentiation
  • Challenges in Drug Interactions and Contraindications Highlight the Need for Pharmacist-Backed Education
  • Retail Store Loyalty Programs and Bundled Promotions Strengthen Consumer Retention in OTC Categories
  • Growing Use of OTC Analgesics in Minor Sports Injuries Supports Expansion in Youth and Active Lifestyles
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Over-the-Counter Pain Medication Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Over-the-Counter Pain Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Non-steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Non-steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Non-steroidal Anti-inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Local Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Acetaminophen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Acetaminophen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Acetaminophen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Salicylates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Salicylates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Salicylates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Liquids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Creams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Tablets / Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Tablets / Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Tablets / Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 53: USA Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• JAPAN
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• CHINA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 89: China Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• EUROPE
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Over-the-Counter Pain Medication by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• FRANCE
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 116: France Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: France 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• GERMANY
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Germany 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Italy 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 152: UK Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: UK 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Spain 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Russia 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Australia 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• INDIA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 227: India Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: India 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: South Korea 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Over-the-Counter Pain Medication by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Argentina 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Brazil 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Mexico 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Over-the-Counter Pain Medication by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Iran 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Israel 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: UAE 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030
• AFRICA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Over-the-Counter Pain Medication by Drug Class - Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Over-the-Counter Pain Medication by Drug Class - Percentage Breakdown of Value Sales for Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Over-the-Counter Pain Medication by Dosage Form - Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Over-the-Counter Pain Medication by Dosage Form - Percentage Breakdown of Value Sales for Liquids, Creams, Gels, Other Dosage Forms and Tablets / Capsules for the Years 2015, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Over-the-Counter Pain Medication by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Africa 15-Year Perspective for Over-the-Counter Pain Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Over-the-Counter Pain Medication by Administration Route - Oral, Topical and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Over-the-Counter Pain Medication by Administration Route - Percentage Breakdown of Value Sales for Oral, Topical and Other Administration Routes for the Years 2015, 2025 & 2030

IV. COMPETITION